Pemphigoid, Bullous
7 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Screening for Adrenal Insufficiency During Dermocorticoid Reduction in Bullous Pemphigoid (BP) (NCT06148090) | University Hospital, Bordeaux | 2024-01-04 |
| The Effects of Tildrakizumab in Treatment of Bullous Pemphigoid (NCT04465292) | Brigham and Women's Hospital | 2020-09-01 |
| A Study to Assess the Therapeutic Effect and Safety of Adjunctive AKST4290 in Subjects With Bullous Pemphigoid (NCT04499235) | Alkahest, Inc. | 2020-01-30 |
| Cytokines in Blister Fluids of Bullous Pemphigoid (BP) (NCT03856840) | Mahmut Can Koska | 2018-01-29 |
| Evaluation of Safety, Efficacy and Pharmacodynamic Effect of Bertilimumab in Patients With Bullous Pemphigoid (NCT02226146) | Alexion Pharmaceuticals, Inc. | 2016-02-29 |
| Role of Proteasomes in a Dermatological Autoimmune Disease: Bullous Pemphigoid (NCT01559155) | Centre Hospitalier Universitaire de Nīmes | 2013-11-05 |
| Anti-IL-5 Therapy in Bullous Pemphigoid (BP) (NCT01705795) | Insel Gruppe AG, University Hospital Bern | 2013-02-13 |
Track Pemphigoid, Bullous automatically
Every clearance here is in the API, with alerts when new ones post.